Skip to main content

Name
Pierce Colpman

Sun, 02/27/2022 - 23:49

In reply to by Emmanuel Fagbola (not verified)

Hey Emmanuel thanks for this great question!
I do think that increasing awareness through something like a public health campaign or equivalent would be a good idea to support antibiotic research. However, I don't know if this would necessarily be enough to impact the large financial barriers that are in place. The points you made regarding omitting doses and the improper usage of antibiotic drugs are major issues, especially in terms of antibiotic resistance, but the lack of support in their development is mostly due to limited profits after they are created. Cardiology drugs can be used by every patient which may benefit from their effects and continued for weeks to years after they are developed. Antibiotic drugs on the other hand are restricted to a small number of cases for resistant organisms. Because of this, the potential profits even from a very successful antibiotic, are shadowed by the initial investment required and even more dwarfed by the potential profits from developing other classes of drugs. I think that more awareness always has the potential to bring more support to a cause but before we see any real change in the support seen for antibiotic research we need to make it a more attractive target for investors, or alternatively, as Alyssa mentioned in her comment, move to a more publicly funded system.

Name
Pierce Colpman

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.